KFDA grants marketing authorization for Cialis tablet

Published: 2003-07-31 07:00:00

Updated: 2003-07-31 07:00:00

The Korea Food and Drug Administration decided to approve Eli Lilly's Cialis tablet for the treatment of erectile dysfunction on July 29 on the condition that Lilly Korea should undertake its side-effects monitoring for six years and in case where this drug is to be proven as a drug of misuse or ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK